• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】11159

【品名】iodomethyl pivalate

【CA登记号】

【 分 子 式 】C6H11IO2

【 分 子 量 】242.05661

【元素组成】C 29.77% H 4.58% I 52.43% O 13.22%

与该中间体有关的原料药合成路线共 12 条

合成路线1

该中间体在本合成路线中的序号:(II)

1 撒应福,任秉钧.2006.头孢类抗生素的制备方法,发明专利申请公开说明书.CN 1763046
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 66165 sodium (6S,7S)-7-((Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate   C14H14NaN5O6S2 详情 详情
(II) 11159 iodomethyl pivalate C6H11IO2 详情 详情
(III) 66166 (6R,7R)-tert-butoxymethyl 7-((E)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate   C19H25N5O7S2 详情 详情
(IV) 66167 (6S,7S)-tert-butoxymethyl 7-((E)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-(chloromethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate   C19H24ClN5O6S2 详情 详情
(V) 66168 (6R,7R)-tert-butoxymethyl 7-((E)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-(iodomethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate   C19H24IN5O6S2 详情 详情
(VI) 66169 (((6S,7S)-7-((E)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-2-((tert-butoxymethoxy)carbonyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl)methyl)triphenylphosphonium iodide   C37H39IN5O6S2P 详情 详情
(VII) 66170 (6R,7R)-tert-butoxymethyl 7-((E)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-3-((triphenylphosphoranylidene)methyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate, iodide salt   C37H38N5O6S2P 详情 详情
(VIII) 11153 4-Methyl-1,3-thiazole-5-carbaldehyde 82294-70-0 C5H5NOS 详情 详情

合成路线2

该中间体在本合成路线中的序号:(IX)

The reaction of 3-(chloromethyl)-7-(phenylacetamido)-3-cephem-4-carboxylic acid 4-methoxybenzyl ester (I) with triphenylphosphine and NaI in acetone gives the corresponding phosphonium salt (II), which is condensed with 4-methylthiazole-5-carboxaldehyde (III) by means of NaHCO3 in dichloromethane affording 3-[2(Z)-(4-methylthiazol-5-yl)vinyl]-7-(phenylacetamido)-3-cephem-4-carboxylic acid 4-methoxybenzyl ester (IV). The cleavage of the amido group of (IV) with PCl5 and pyridine yields the 7-amino compound (V), which is condensed with 2-(methoxyimino)-2-[2-(tritylamino)thiazol-4-yl]acetic acid (VI) by means of POCl3 in dichloromethane giving 3-[2(Z)-(4-methylthiazol-5-yl)vinyl]-7-[2(Z)-methoxyimino)-2-(2-tritylamino)thiazol-4-yl)acetamido]-3-cephem-4-carboxylic acid 4-methoxybenzyl ester (VII). The deprotection of (VII) with trifluoroacetic acid and anisole yields the free amino acid (VIII), which is finally esterified with iodomethyl pivalate (IX) in DMF.

1 Yamamoto, Y.; Yoshida, T.; Tamura, A.; Atsumi, K.; Fukatsu, S.; Sakagami, K.; Nishihata, K.; Synthesis and oral activity of pivaloyloxymethyl 7-[(Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido]-3(Z)--(4-methylthiazol-5-yl)vinyl-3-cephem-4-carboxylate (ME1207) and its related compound. Chem Pharm Bull 1992, 39, 9, 2433.
2 Atsumi, K.; Sakagami, K.; Yamamoto, Y.; Yoshida, T.; Nishihata, K.; Kondo, S.; Fukatsu, S. (Meiji Seika Kaisha, Ltd.); New cephalosporin cpds. and the production thereof. EP 0175610; ES 8704955; JP 1986178991; JP 1987019593 .
3 Castaner, J.; Prous, J.; Cefditoren Pivoxil. Drugs Fut 1992, 17, 8, 665.
4 Sakagami, K.; Tamura, A.; Yoshida, T.; Nishihata, K.; Fukatsu, S.; Atsumi, K.; Synthesis and oral activity of ME1207, a new orally active cephalosporin. J Antibiot 1990, 43, 8, 1047.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 11151 4-methoxybenzyl (7R)-3-(chloromethyl)-8-oxo-7-[(2-phenylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate 104146-10-3 C24H23ClN2O5S 详情 详情
(II) 11152 4-methoxybenzyl (7R)-8-oxo-7-[(2-phenylacetyl)amino]-3-[(triphenylphosphoranyl)methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate C42H39N2O5PS 详情 详情
(III) 11153 4-Methyl-1,3-thiazole-5-carbaldehyde 82294-70-0 C5H5NOS 详情 详情
(IV) 11154 4-methoxybenzyl (7R)-3-[(Z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-8-oxo-7-[(2-phenylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate C29H27N3O5S2 详情 详情
(V) 11155 4-methoxybenzyl (7R)-7-amino-3-[(Z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate C21H21N3O4S2 详情 详情
(VI) 11156 2-(Methoxyimino)-2-[2-(tritylamino)-1,3-thiazol-4-yl]acetamide C25H22N4O2S 详情 详情
(VII) 11157 4-methoxybenzyl (7R)-7-[[2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino]-3-[(Z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate C27H26N6O6S3 详情 详情
(VIII) 11158 (7R)-7-[[2-(2-Amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino]-3-[(Z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid C19H18N6O5S3 详情 详情
(IX) 11159 iodomethyl pivalate C6H11IO2 详情 详情

合成路线3

该中间体在本合成路线中的序号:(X)

Coupling of ethyl glyoxylate derivative (I) with Boc-L-Alanine (II) by means of EDC and DMAP in DMF provides compound (III), whose ethyl ester is subjected to saponification by treatment with NaOH in EtOH to furnish carboxylic acid (IV). Condensation of (IV) with methoxyamine (NH2OMe) in THF/H2O yields methoxyimino acetic acid derivative (V), which is then coupled to pivaloyloxymethyl 7-amino-3-cephem-4-carboxylate (VI) in CH2Cl2 by means of phosphorus oxychloride (POCl3) in DMF/EtOAc and N-trimethylsilylacetamide to give compound (VII). Finally, the desired compound is obtained after treatment of (VII) with TFA and anisole in CH2Cl2 for Boc removal . Alternatively, methoxyimino acetic acid derivative (V) can be converted into intermediate (VII) by coupling with 7-amino-3-cephem-4-carboxylic acid (VIII) by means of POCl3 in DMF/EtOAc and N-trimethylsilylacetamide in CH2Cl2 to provide derivative (IX), followed by condensation with iodomethyl pivalate (X) by means of potassium acetate in DMF.

1 Muro, H.; Kasai, M.; Hatano, s.; Nishimura, K.-I.; Nishizawa, S.; Kakeya, N. (Kyoto Pharmaceutical Industries, Ltd.); Cephalosporin cpds. and production thereof. EP 0497978; JP 1991204883; US 5389625; WO 9106549 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 49506 Ethyl 2-amino-4-thiazoleglyoxylate C7H8N2O3S 详情 详情
(II) 26450 Boc-L-Alanine;(S)-2-((tert-butoxycarbonyl)amino)propanoic acid;N-Boc-L-alanine; (2S)-2-[(tert-butoxycarbonyl)amino]propionic acid 15761-38-3 C8H15NO4 详情 详情
(III) 49507 ethyl 2-[2-([(2S)-2-[(tert-butoxycarbonyl)amino]propanoyl]amino)-1,3-thiazol-4-yl]-2-oxoacetate C15H21N3O6S 详情 详情
(IV) 49508 2-[2-([(2S)-2-[(tert-butoxycarbonyl)amino]propanoyl]amino)-1,3-thiazol-4-yl]-2-oxoacetic acid C13H17N3O6S 详情 详情
(V) 49509 2-[2-([(2S)-2-[(tert-butoxycarbonyl)amino]propanoyl]amino)-1,3-thiazol-4-yl]-2-(methoxyimino)acetic acid C14H20N4O6S 详情 详情
(VI) 49510 [(2,2-dimethylpropanoyl)oxy]methyl (6R,7R)-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate C13H18N2O5S 详情 详情
(VII) 49511 [(2,2-dimethylpropanoyl)oxy]methyl (6R,7R)-7-[[2-[2-([(2S)-2-[(tert-butoxycarbonyl)amino]propanoyl]amino)-1,3-thiazol-4-yl]-2-(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate C27H36N6O10S2 详情 详情
(VIII) 49512 (6R,7R)-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid C7H8N2O3S 详情 详情
(IX) 49513 (6R,7R)-7-[[2-[2-([(2S)-2-[(tert-butoxycarbonyl)amino]propanoyl]amino)-1,3-thiazol-4-yl]-2-(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid C21H26N6O8S2 详情 详情
(X) 11159 iodomethyl pivalate C6H11IO2 详情 详情

合成路线4

该中间体在本合成路线中的序号:(X)

Coupling of pivaloyloxymethyl 7-amino-3-cephem-4-carboxylate (VI) and methoxyimino acetic acid derivative (XI) by means of POCl3 and pyridine in CH2Cl2 gives compound (XII) (alternatively (XII) can be obtained by condensation of ceftizoxime (CZX) (XIII) with iodomethyl pivalate (X) in N,N-dimethylacetamide (DMAc) in the presence of dicyclohexylamine). Coupling of (XII) with Boc-L-alanine (II) by means of EDC and DMAP in CH2Cl2 gives intermediate (VII), whose Boc protecting group is removed by treatment with either HCl/isopropanol in formic acid or TFA and anisole in CH2Cl2. Yet another strategy can be followed, involving the coupling of pivaloyloxymethyl 7-amino-3-cephem-4-carboxylate (VI) with derivative (XIV) by means of Et3N in N,N-dimethylacetamide.

1 Shirahase, H.; Hatano, S.; Yoshimi, A.; Kitagawa, M.; Kasai, M.; Nishimura, K.; Kakeya, N.; AS-924, a novel bifunctional prodrug of ceftizoxime. J Antibiot 1999, 52, 5, 491.
2 Kasai, M.; et al.; AS-924, a novel orally active bifunctional prodrug of ceftizoxime. Synthesis and relationship between physicochemical properties and oral absorption. Chem Pharm Bull 1999, 47, 8, 1081.
3 Muro, H.; Kasai, M.; Hatano, s.; Nishimura, K.-I.; Nishizawa, S.; Kakeya, N. (Kyoto Pharmaceutical Industries, Ltd.); Cephalosporin cpds. and production thereof. EP 0497978; JP 1991204883; US 5389625; WO 9106549 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(II) 26450 Boc-L-Alanine;(S)-2-((tert-butoxycarbonyl)amino)propanoic acid;N-Boc-L-alanine; (2S)-2-[(tert-butoxycarbonyl)amino]propionic acid 15761-38-3 C8H15NO4 详情 详情
(VI) 49510 [(2,2-dimethylpropanoyl)oxy]methyl (6R,7R)-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate C13H18N2O5S 详情 详情
(VII) 49511 [(2,2-dimethylpropanoyl)oxy]methyl (6R,7R)-7-[[2-[2-([(2S)-2-[(tert-butoxycarbonyl)amino]propanoyl]amino)-1,3-thiazol-4-yl]-2-(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate C27H36N6O10S2 详情 详情
(X) 11159 iodomethyl pivalate C6H11IO2 详情 详情
(XI) 24737 2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetic acid 65872-41-5 C6H7N3O3S 详情 详情
(XII) 49514 [(2,2-dimethylpropanoyl)oxy]methyl (6R,7R)-7-[[2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate C19H23N5O7S2 详情 详情
(XIII) 49515 (6R,7R)-7-[[2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid C13H13N5O5S2 详情 详情
(XIV) 49516 2-(2-[[(2S)-2-aminopropanoyl]amino]-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl chloride C9H11ClN4O3S 详情 详情

合成路线5

该中间体在本合成路线中的序号:(VI)

Adefovir dipivoxil can be obtained by two similar ways: 1) The reaction of adenine (I) with 2-(diisopropoxyphosphorylmethoxy)ethyl methanesulfonate (II) by means of cesium carbonate in DMF gives the expected condensation product (III), which is converted into the phosphonic acid (IV) by treatment with trimethylsilyl bromide in acetonitrile (1). Finally, this compound is condensed with chloromethyl pivalate (V) by means of N,N'-dicyclohexylmorpholine-4-carboxamidine in DMF. 2) The final condensation of the phosphonic acid (IV) can also be performed with iodomethyl pivalate (VI) in pyridine.

1 Benzaria, S.; Pélicano, H.; Johnson, R.; Maury, G.; Imbach, J.-L.; Aubertin, A.-M.; Obert, G.; Gosselin, G.; Synthesis, in vitro antiviral evaluation, and stability studies of bis(S-acyl-2-thioethyl) ester derivatives of 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA) as potential PMEA prodrugs with improved oral bioavailability. J Med Chem 1996, 39, 25, 4958-65.
2 Prous, J.; Graul, A.; Castaner, J.; Adefovir Dipivoxil. Drugs Fut 1997, 22, 8, 825.
3 Starrett, J.E. Jr.; Mansuri, M.M.; Martin, J.C.; Tortolani, D.R.; Bronson, J.J. (Bristol-Myers Squibb Co.); Prodrug of phosphonates. EP 0481214; JP 1992230694 .
4 Starrett, J.E. Jr.; Tortolani, D.R.; Russell, J.; Hitchcock, M.J.M.; Whiterock, V.; Martin, J.C.; Mansuri, M.M.; Synthesis, oral bioavailability determination, and in vitro evaluation of prodrugs of the antiviral agent 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA). J Med Chem 1994, 37, 12, 1857-64.
5 Starrett, J.E. Jr.; et al.; Synthesis and in vitro evaluation of a phosphonate prodrug: bis(pivaloyloxymethyl) 9-(2-phosphonylmethoxyethyl)adenine. Antivir Res 1992, 19, 3, 267-73.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 10343 9H-Purin-6-amine; 9H-Purin-6-ylamine; Adenine 73-24-5 C5H5N5 详情 详情
(II) 16163 2-[(diisopropoxyphosphoryl)methoxy]ethyl methanesulfonate C10H23O7PS 详情 详情
(III) 16164 diisopropyl [2-(6-amino-9H-purin-9-yl)ethoxy]methylphosphonate C14H24N5O4P 详情 详情
(IV) 16165 [2-(6-amino-9H-purin-9-yl)ethoxy]methylphosphonic acid C8H12N5O4P 详情 详情
(V) 16166 chloromethyl pivalate 18997-19-8 C6H11ClO2 详情 详情
(VI) 11159 iodomethyl pivalate C6H11IO2 详情 详情

合成路线6

该中间体在本合成路线中的序号:(XVIII)

Finally, the target compound has been obtained as follows: The selective esterification of the phosphono group of intermediate (IX) with iodomethyl pivalate (XVIII) by means of triethylamine in DMF gives the sulfonic acid (XIX), which was purified through its calcium salt. Finally, this compound is treated with tert-butylamine in methanol to afford the target salt.

1 Pendri, Y.; Chen, C.-P.; Kucera, D.J.; Martinez, E.J.; Pansegrau, P.; Thottathil, J.K.; Timmins, P. (Bristol-Myers Squibb Co.); Phosphonosulfonate squalene synthetase inhibitor salts and method. CA 2159850; EP 0710665; JP 1996208672 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(IX) 30173 (1S)-4-(3-phenoxyphenyl)-1-phosphono-1-butanesulfonic acid C16H19O7PS 详情 详情
(XVIII) 11159 iodomethyl pivalate C6H11IO2 详情 详情
(XIX) 30182 (1S)-1-(bis[[(2,2-dimethylpropanoyl)oxy]methoxy]phosphoryl)-4-(3-phenoxyphenyl)-1-butanesulfonic acid C28H39O11PS 详情 详情
(XX) 17895 2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine 75-64-9 C4H11N 详情 详情

合成路线7

该中间体在本合成路线中的序号:(IX)

1) The mesylation of 4(S)-hydroxypyrrolidin-2-one (I) with mesyl chloride and triethylamine in pyridine gives the corresponding ester (II), which is treated with potassium thioacetate (III) in refluxing acetonitrile yielding 4(R)-(acetylsulfanyl)pyrrolidin-2-one (IV). The hydrolysis of (IV) with sodium methoxide in methanol followed by acidification with aqueous HCl affords 4(R)-sulfanylpyrrolidin-2-one (V), which is condensed with (1R,5S,6S)-2-(diphenoxyphosphoryloxy)-6-[1(R)-hydroxyethyl]-1-methyl-1-carba-2-penem-3-carboxylic acid p-nitrobenzyl ester (VI) by means of ethyldiisopropylamine in acetonitrile to give (1R,5S,6S)-6-[1(R)-hydroxyethyl]-1-methyl-2-[5-oxopyrrolidin-3(R)-ylsulfanyl]-1-carba-2-penem-3-carboxylic acid p-nitrobenzyl ester (VII). The hydrogenolysis of (VII) with H2 over Pd/C in THF/aqueous phosphate buffer yields the sodium salt (VIII), which is finally esterified with pivaloyloxymethyl iodide (IX) in dimethylacetamide.

1 Yasuda, H.; Kuwahara, S.; Kawamoto, I.; Miyauchi, M.; Endo, R.; Hisaoka, M.; CS-834, a new oral carbapenem: I. Structure-activity relationships of 2-substituted 1beta-methylcarbapenems. 36th Intersci Conf Antimicrob Agents Chemother (Sept 15-18, New Orleans) 1996, Abst F105.
2 Endo, R.; Yasuda, H.; Kawamoto, I.; Hisaoka, M.; Miyauchi, M.; Synthesis and structure-activity relationships of a novel oral carbapenem, CS-834. J Antibiot 1997, 50, 5, 429-39.
3 Graul, A.; Castañer, R.M.; Castañer, J.; Leeson, P.; CS-834. Drugs Fut 1998, 23, 3, 261.
4 Kawamoto, I.; Tanaka, T.; Endo, R.; Miyauchi, M.; Iwata, M. (Sankyo Co., Ltd.); 2-(Heterocyclylthio)carbapenem derivs. their preparation and their use as antibiotics. AU 8932386; EP 0337637; EP 0597821; JP 1990028180; JP 1990049783; US 5104867; US 5242914 .
5 Kawamoto, I.; Miyauchi, M.; Endo, R. (Sankyo Co., Ltd.); Crystalline carbapenem deriv. EP 0599512; JP 1995165759 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 17188 (S)-4-hydroxy-2-pyrrolidone; (4S)-4-hydroxytetrahydro-2H-pyrrol-2-one; (S)-4-hydroxypyrrolidone 68108-18-9 C4H7NO2 详情 详情
(II) 17189 (3S)-5-oxotetrahydro-1H-pyrrol-3-yl methanesulfonate C5H9NO4S 详情 详情
(III) 17190 potassium ethanethioate 10387-40-3 C2H3KOS 详情 详情
(IV) 17191 S-[(3R)-5-oxotetrahydro-1H-pyrrol-3-yl] ethanethioate C6H9NO2S 详情 详情
(V) 17192 (4R)-4-sulfanyltetrahydro-2H-pyrrol-2-one 157429-42-0 C4H7NOS 详情 详情
(VI) 13224 4-nitrobenzyl (4R,5R,6S)-3-[(diphenoxyphosphoryl)oxy]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate 90776-59-3 C29H27N2O10P 详情 详情
(VII) 17194 4-nitrobenzyl (4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-3-[[(3R)-5-oxotetrahydro-1H-pyrrol-3-yl]sulfanyl]-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate C21H23N3O7S 详情 详情
(VIII) 17195 sodium (4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-3-[[(3R)-5-oxopyrrolidinyl]sulfanyl]-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate C14H17N2NaO5S 详情 详情
(IX) 11159 iodomethyl pivalate C6H11IO2 详情 详情

合成路线8

该中间体在本合成路线中的序号:(XII)

A short-step synthesis of CS-834 has been described: The condensation of azetidinone (I) with pyrrolidinone (II) by means of CDI gives the thioester (III), which is desilylated with BF3/Et2O to the alcohol (IV). In order to have a more labile protecting group, alcohol (IV) is resilylated with TMS-Cl (or TES-Cl) and triethylamine affording the silyl ether (V), which is protected again at the pyrrolidine nitrogen with TES-Cl, affording the disilylated azetidinone (VI). The condensation of (VI) with the oxalyl chloride (VII) by means of triethylamine in dichloromethane gives the expected oxalylazetidinone (VIII), which is treated with diethyl ethylphosphonite in toluene yielding the ylide (IX). This compound, without isolation, is cyclized in refluxing mesitylene to afford the protected carbapenem intermediate (X), which is finally desilylated with HCl in acetonitrile. The cyclization of azetidinone (VIII) to carbapenem (X) can also be performed with triethyl phosphite instead of diethyl ethylphosphonite. The oxalyl chloride (VII) is obtained by monoesterification of oxalic acid (XI) with pivaloyloxymethyl iodide (XII) by means of triethylamine yielding monoester (XIII), which is finally converted to intermediate (VII) by treatment with oxalyl chloride in dichloromethane.

1 Oida, S.; Mori, M.; A short-step synthesis of orally active carbapenem antibiotic CS-834. Chem Pharm Bull 2000, 48, 1, 126.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 30029 (2R)-2-[(2S,3S)-3-((1R)-1-[[tert-butyl(dimethyl)silyl]oxy]ethyl)-4-oxoazetidinyl]propionic acid C14H27NO4Si 详情 详情
(II) 17192 (4R)-4-sulfanyltetrahydro-2H-pyrrol-2-one 157429-42-0 C4H7NOS 详情 详情
(III) 33402 S-[(3R)-5-oxopyrrolidinyl] (2R)-2-[(2S,3S)-3-((1R)-1-[[tert-butyl(dimethyl)silyl]oxy]ethyl)-4-oxoazetidinyl]propanethioate C18H32N2O4SSi 详情 详情
(IV) 33403 S-[(3R)-5-oxopyrrolidinyl] (2R)-2-[(2S,3S)-3-[(1R)-1-hydroxyethyl]-4-oxoazetidinyl]propanethioate C12H18N2O4S 详情 详情
(V) 33404 S-[(3R)-5-oxopyrrolidinyl] (2R)-2-((2S,3S)-4-oxo-3-[(1R)-1-[(trimethylsilyl)oxy]ethyl]azetidinyl)propanethioate C15H26N2O4SSi 详情 详情
(VI) 33405 S-[(3R)-5-oxo-1-(triethylsilyl)pyrrolidinyl] (2R)-2-((2S,3S)-4-oxo-3-[(1R)-1-[(trimethylsilyl)oxy]ethyl]azetidinyl)propanethioate C21H40N2O4SSi2 详情 详情
(VII) 17199 [(2-chloro-2-oxoacetyl)oxy]methyl pivalate C8H11ClO5 详情 详情
(VIII) 33406 [[2-((2S,3S)-2-((1R)-1-methyl-2-oxo-2-[[(3R)-5-oxo-1-(triethylsilyl)pyrrolidinyl]sulfanyl]ethyl)-4-oxo-3-[(1R)-1-[(trimethylsilyl)oxy]ethyl]azetidinyl)-2-oxoacetyl]oxy]methyl pivalate C29H50N2O9SSi2 详情 详情
(IX) 33407 [[2-[diethoxy(ethyl)phosphoranylidene]-2-((2S,3S)-2-((1R)-1-methyl-2-oxo-2-[[(3R)-5-oxo-1-(triethylsilyl)pyrrolidinyl]sulfanyl]ethyl)-4-oxo-3-[(1R)-1-[(trimethylsilyl)oxy]ethyl]azetidinyl)acetyl]oxy]methyl pivalate C35H65N2O10PSSi2 详情 详情
(X) 33408 [(2,2-dimethylpropanoyl)oxy]methyl (4R,5S,6S)-4-methyl-7-oxo-3-[[(3R)-5-oxo-1-(triethylsilyl)pyrrolidinyl]sulfanyl]-6-[(1R)-1-[(trimethylsilyl)oxy]ethyl]-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate C29H50N2O7SSi2 详情 详情
(XI) 15713 Oxalic acid 144-62-7 C2H2O4 详情 详情
(XII) 11159 iodomethyl pivalate C6H11IO2 详情 详情
(XIII) 33409 2-[[(2,2-dimethylpropanoyl)oxy]methoxy]-2-oxoacetic acid C8H12O6 详情 详情

合成路线9

该中间体在本合成路线中的序号:(XIXa)

Condensation of (phosphoryloxy)carbapenem (XVI) with 3-mercapto-1-(1,3-thiazolin-2-yl)azetidine (XI) gave thioether (XVII). The p-nitrobenzyl ester group of (XVII) was then deprotected with Zn powder to afford carboxylic acid. Finally, treatment of (XVIII) with either iodo or chloromethyl pivalate (XIX) produced the target compound.

1 Satoh, C.; Mihira, A.; Yamamoto, S.; Hayashi, K.; Kitamura, M.; Tamai, S.; Abe, T.; Kumagai, T.; Hikida, M.; L-084, a new oral carbapenem: Synthesis and structure-activity relationships of C2-substituted 1beta-methylcarbapenems. 38th Intersci Conf Antimicrob Agents Chemother (Sept 24 1998, San Diego) 1998, Abst F-64.
2 Abe, T.; Isoda, T.; Sato, C.; Mihira, A.; Tamai, S.; Kumagai, T. (Lederle (Japan), Ltd.); 2-(1-(1,3-Thiazolin-2-yl)azetidin-3-yl)thio-carbapenem derivs.. EP 0632039; EP 0717042; JP 1996053453; US 5534510; US 5659043; US 5783703 .
3 Abe, T.; Kumagai, T. (Lederle (Japan), Ltd.); Carbapenem-3-carboxylic acid ester derivs.. EP 0808315; JP 1999504039; US 5886172; WO 9721712 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XIXa) 11159 iodomethyl pivalate C6H11IO2 详情 详情
(XIXb) 16166 chloromethyl pivalate 18997-19-8 C6H11ClO2 详情 详情
(XI) 31404 1-(4,5-dihydro-1,3-thiazol-2-yl)-3-azetidinylhydrosulfide; 1-(4,5-dihydro-1,3-thiazol-2-yl)-3-azetidinethiol 179337-57-6 C6H10N2S2 详情 详情
(XVI) 13224 4-nitrobenzyl (4R,5R,6S)-3-[(diphenoxyphosphoryl)oxy]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate 90776-59-3 C29H27N2O10P 详情 详情
(XVII) 31408 4-nitrobenzyl (4R,5S,6S)-3-[[1-(4,5-dihydro-1,3-thiazol-2-yl)-3-azetidinyl]sulfanyl]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate C23H26N4O6S2 详情 详情
(XVIII) 31409 (4R,5S,6S)-3-[[1-(4,5-dihydro-1,3-thiazol-2-yl)-3-azetidinyl]sulfanyl]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid C16H21N3O4S2 详情 详情

合成路线10

该中间体在本合成路线中的序号:(X)

Protection of alcohol (I) with TBDMSCl and imidazole gives silyl compound (II) which is N-methylated by means of NaH and MeI and then deprotected with HCl to yield derivative (III). Mesylation of (III) with MsCl in presence of Et3N followed by thioacetylation with AcSK (A) affords thioacetate (IV) which is then hydrolyzed with NaOMe to yield (V). Treatment of (VI) with diphenylphosphoryl chloride (B) and DIEA in acetonitrile yields (VII), which is then condensed with mercaptan (V) by means of DIEA in the same solvent to provide carbapenem (VIII). Deprotection of the carboxyl moiety of (VIII) by hydrogenation with H2 over Pd/C affords carboxylate (IX), which is finally esterified with pivaloyloxymethyl iodide (X) in N,N-dimethylacetamide or DMF.

1 Miyauchi, M.; Ohya, S.; Kawamoto, I.; Shibayama, T.; Kanno, O.; Synthesis and biological evaluation of new oral carbapenems with 1-methyl-5-oxopyrrolidin-3-ylthio moiety. J Antibiot 1999, 52, 10, 900.
2 Kawamoto, I.; Tanaka, T.; Endo, R.; Miyauchi, M.; Iwata, M. (Sankyo Co., Ltd.); 2-(Heterocyclylthio)carbapenem derivs. their preparation and their use as antibiotics. AU 8932386; EP 0337637; EP 0597821; JP 1990028180; JP 1990049783; US 5104867; US 5242914 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(B) 16074 Diphenyl phosphoryl chloride; 1,1'-Diphenylphosphoryl chloride; Chlorodiphenyl Phosphate; Diphenyl chlorophosphate; Diphenylchlorophosphate 2524-64-3 C12H10ClO3P 详情 详情
(A) 17190 potassium ethanethioate 10387-40-3 C2H3KOS 详情 详情
(I) 17188 (S)-4-hydroxy-2-pyrrolidone; (4S)-4-hydroxytetrahydro-2H-pyrrol-2-one; (S)-4-hydroxypyrrolidone 68108-18-9 C4H7NO2 详情 详情
(II) 41640 (4S)-4-[[tert-butyl(dimethyl)silyl]oxy]-2-pyrrolidinone C10H21NO2Si 详情 详情
(III) 41641 (4S)-4-hydroxy-1-methyl-2-pyrrolidinone C5H9NO2 详情 详情
(IV) 41642 S-[(3R)-1-methyl-5-oxopyrrolidinyl] ethanethioate C7H11NO2S 详情 详情
(V) 41643 (4R)-1-methyl-4-sulfanyl-2-pyrrolidinone C5H9NOS 详情 详情
(VI) 37720 4-nitrobenzyl (4R,5R,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-3,7-dioxo-1-azabicyclo[3.2.0]heptane-2-carboxylate C17H18N2O7 详情 详情
(VII) 13224 4-nitrobenzyl (4R,5R,6S)-3-[(diphenoxyphosphoryl)oxy]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate 90776-59-3 C29H27N2O10P 详情 详情
(VIII) 41644 4-nitrobenzyl (4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-3-[[(3R)-1-methyl-5-oxopyrrolidinyl]sulfanyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate C22H25N3O7S 详情 详情
(IX) 41645 sodium (4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-3-[[(3R)-1-methyl-5-oxopyrrolidinyl]sulfanyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate C15H19N2NaO5S 详情 详情
(X) 11159 iodomethyl pivalate C6H11IO2 详情 详情

合成路线11

该中间体在本合成路线中的序号:(XI)

Alcohol (I) is protected with TBDMSCl and imidazole to give silyl compound (II), which is N-methylated by means of NaH and MeI and then deprotected with HCl to yield derivative (III). Mitsunobu reaction of (III) with 4-nitrobenzoic acid in presence of PPh3 and DEAD, followed by ester hydrolysis with K2CO3, provides alcohol (IV). Mesylation of (IV) with MsCl in presence of Et3N, followed by thioacetylation with AcSK (A), affords thioacetate (V), which is then hydrolyzed with NaOMe to yield (VI). Treatment of (VII) with diphenylphosphoryl chloride (B) in CH3CN and DIEA in CH3CN yields (VIII), which is then condensed with mercaptan (VI) by means of DIEA in the same solvent to provide carbapenem (IX). Deprotection of the carboxyl moiety of (IX) by hydrogenation with H2 over Pd/C affords carboxylate (X), which is finally esterified with pivaloyloxymethyl iodide (XI) in N,N-dimethylacetamide or DMF.

1 Miyauchi, M.; Ohya, S.; Kawamoto, I.; Shibayama, T.; Kanno, O.; Synthesis and biological evaluation of new oral carbapenems with 1-methyl-5-oxopyrrolidin-3-ylthio moiety. J Antibiot 1999, 52, 10, 900.
2 Kawamoto, I.; Tanaka, T.; Endo, R.; Miyauchi, M.; Iwata, M. (Sankyo Co., Ltd.); 2-(Heterocyclylthio)carbapenem derivs. their preparation and their use as antibiotics. AU 8932386; EP 0337637; EP 0597821; JP 1990028180; JP 1990049783; US 5104867; US 5242914 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(B) 16074 Diphenyl phosphoryl chloride; 1,1'-Diphenylphosphoryl chloride; Chlorodiphenyl Phosphate; Diphenyl chlorophosphate; Diphenylchlorophosphate 2524-64-3 C12H10ClO3P 详情 详情
(A) 17190 potassium ethanethioate 10387-40-3 C2H3KOS 详情 详情
(I) 17188 (S)-4-hydroxy-2-pyrrolidone; (4S)-4-hydroxytetrahydro-2H-pyrrol-2-one; (S)-4-hydroxypyrrolidone 68108-18-9 C4H7NO2 详情 详情
(II) 41640 (4S)-4-[[tert-butyl(dimethyl)silyl]oxy]-2-pyrrolidinone C10H21NO2Si 详情 详情
(III) 41641 (4S)-4-hydroxy-1-methyl-2-pyrrolidinone C5H9NO2 详情 详情
(IV) 41648 (4R)-4-hydroxy-1-methyl-2-pyrrolidinone C5H9NO2 详情 详情
(V) 41649 S-[(3S)-1-methyl-5-oxopyrrolidinyl] ethanethioate C7H11NO2S 详情 详情
(VI) 41650 (4S)-1-methyl-4-sulfanyl-2-pyrrolidinone C5H9NOS 详情 详情
(VII) 37720 4-nitrobenzyl (4R,5R,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-3,7-dioxo-1-azabicyclo[3.2.0]heptane-2-carboxylate C17H18N2O7 详情 详情
(VIII) 13224 4-nitrobenzyl (4R,5R,6S)-3-[(diphenoxyphosphoryl)oxy]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate 90776-59-3 C29H27N2O10P 详情 详情
(IX) 41646 4-nitrobenzyl (4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-3-[[(3S)-1-methyl-5-oxopyrrolidinyl]sulfanyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate C22H25N3O7S 详情 详情
(X) 41647 sodium (4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-3-[[(3S)-1-methyl-5-oxopyrrolidinyl]sulfanyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate C15H19N2NaO5S 详情 详情
(XI) 11159 iodomethyl pivalate C6H11IO2 详情 详情

合成路线12

该中间体在本合成路线中的序号:(XV)

Alkylation of 4,5,6,7-tetrahydro-1,2-benzisoxazol-3-ol (I) with ethyl bromide in the presence of K2CO3 afforded the ethoxy derivative (II). Subsequent oxidation of (II) with sodium dichromate and H2SO4 provided the desired ketone (III) along with minor amounts of the isomeric 7-oxo compound (IV) that were separated by column chromatography. Conversion of (III) to the corresponding oxime (V), followed by reduction with aluminum amalgam yielded amine (VI). Resolution was achieved via formation of the diastereomeric amides with (R)-alpha-methoxyphenylacetyl chloride (VII) and isolation of the desired isomer (VIII) by preparative HPLC. Cleavage of amide and ether groups of (VIII) by means of HBr furnished (R)-4-amino-3-hydroxy-4,5,6,7-tetrahydro-1,2-benzisoxazole (IX). Protection as the corresponding tert-butyl carbamate, followed by N-methylation with CH3I and NaH provided intermediate (X). An alternative procedure for the preparation of intermediate (X) consisted in the reductive amination of ketone (III) with methylamine and NaBH3CN, followed by condensation of the resulting amine (XI) with the chiral acid chloride (VII) and chromatographic isolation of the desired diastereoisomer (XII). The alpha-methoxyphenylacetyl group of (XII) was then removed by an alternative method consisting in the treatment with lithium triethylborohydride to give the chiral amine (XIII). Cleavage of the ethyl ether group of (XIII) was effected by means of HBr in AcOH, and the resulting compound (XIV) was condensed with di-tert-butyl dicarbonate to produce carbamate (X). Subsequent reaction of (X) with pivaloyloxymethyl iodide (XV) in the presence of potassium tert-butoxide yielded the target O-alkylated compound (XVI) along with some N-alkylated regioisomer. The Boc protecting group of (XVI) was finally removed by treatment with trifluoroacetic acid.

1 Frolund, B.; Falch, E.; Perregaard, J.; et al.; Selective inhibitors of glial GABA uptake: Synthesis, absolute stereochemistry, and pharmacology of the enantiomers of 3-hydroxy-4-amino-4,5,6,7-tetrahydro-1,2-benzisoxazole (exo-THPO) and analogues. J Med Chem 1999, 42, 26, 5402.
2 Falch, E.; Moltzen, L.S.; Schousboe, A.; Frolund, B.; Perregaard, J.K.; Krogsgaard-Larsen, P. (H. Lundbeck A/S); 4-Aminotetrahydrobenzisoxazole or -isothiazole cpds.. WO 9626929 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
11021 Methanamine; Methylamine 74-89-5 CH5N 详情 详情
(I) 37236 4,5,6,7-tetrahydro-1,2-benzisoxazol-3-ol C7H9NO2 详情 详情
(II) 37237 ethyl 4,5,6,7-tetrahydro-1,2-benzisoxazol-3-yl ether; 3-ethoxy-4,5,6,7-tetrahydro-1,2-benzisoxazole C9H13NO2 详情 详情
(III) 37238 3-ethoxy-6,7-dihydro-1,2-benzisoxazol-4(5H)-one C9H11NO3 详情 详情
(IV) 37239 3-ethoxy-5,6-dihydro-1,2-benzisoxazol-7(4H)-one C9H11NO3 详情 详情
(V) 37240 3-ethoxy-6,7-dihydro-1,2-benzisoxazol-4(5H)-one oxime C9H12N2O3 详情 详情
(VI) 37241 3-ethoxy-4,5,6,7-tetrahydro-1,2-benzisoxazol-4-amine; 3-ethoxy-4,5,6,7-tetrahydro-1,2-benzisoxazol-4-ylamine C9H14N2O2 详情 详情
(VII) 16302 (2R)-2-methoxy-2-phenylethanoyl chloride C9H9ClO2 详情 详情
(VIII) 37242 (2R)-N-[(4R)-3-ethoxy-4,5,6,7-tetrahydro-1,2-benzisoxazol-4-yl]-2-methoxy-2-phenylethanamide C18H22N2O4 详情 详情
(IX) 37243 (4R)-4-amino-4,5,6,7-tetrahydro-1,2-benzisoxazol-3-ol C7H10N2O2 详情 详情
(X) 34244 methyl 2-[(1R,2R,3R)-2-[(benzyloxy)methyl]-5-[(Z)-2-methoxy-2-oxoethylidene]-3-[(tetrahydro-2H-pyran-2-yloxy)methyl]cyclopentyl]acetate C25H34O7 详情 详情
(XI) 37245 N-(3-ethoxy-4,5,6,7-tetrahydro-1,2-benzisoxazol-4-yl)-N-methylamine; 3-ethoxy-N-methyl-4,5,6,7-tetrahydro-1,2-benzisoxazol-4-amine C10H16N2O2 详情 详情
(XII) 37246 (2R)-N-[(4R)-3-ethoxy-4,5,6,7-tetrahydro-1,2-benzisoxazol-4-yl]-2-methoxy-N-methyl-2-phenylethanamide C19H24N2O4 详情 详情
(XIII) 37247 (4R)-3-ethoxy-N-methyl-4,5,6,7-tetrahydro-1,2-benzisoxazol-4-amine; N-[(4R)-3-ethoxy-4,5,6,7-tetrahydro-1,2-benzisoxazol-4-yl]-N-methylamine C10H16N2O2 详情 详情
(XIV) 37248 (4R)-4-(methylamino)-4,5,6,7-tetrahydro-1,2-benzisoxazol-3-ol C8H12N2O2 详情 详情
(XV) 11159 iodomethyl pivalate C6H11IO2 详情 详情
(XVI) 37249 ([(4R)-4-[(tert-butoxycarbonyl)(methyl)amino]-4,5,6,7-tetrahydro-1,2-benzisoxazol-3-yl]oxy)methyl pivalate C19H30N2O6 详情 详情
Extended Information